Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - Kite Pharma, Inc. | kite-ex312_7.htm |
| EX-31.1 - EX-31.1 - Kite Pharma, Inc. | kite-ex311_6.htm |
| EX-32.1 - EX-32.1 - Kite Pharma, Inc. | kite-ex321_10.htm |
| EX-10.2 - EX-10.2 - Kite Pharma, Inc. | kite-ex102_193.htm |
| EX-10.3 - EX-10.3 - Kite Pharma, Inc. | kite-ex103_166.htm |
| EX-10.1 - EX-10.1 - Kite Pharma, Inc. | kite-ex101_196.htm |
| XML - IDEA: XBRL DOCUMENT - Kite Pharma, Inc. | R9999.htm |
| 10-Q - 10-Q - Kite Pharma, Inc. | kite-10q_20150630.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Kite Pharma, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Cynthia M. Butitta, Chief Operating Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
By: |
|
/s/ Cynthia M. Butitta |
|
|
|
Name: Cynthia M. Butitta |
|
|
|
Title: Chief Financial Officer and Chief Operating Officer |
|
Date: August 10, 2015 |
||
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.